Patents by Inventor Bernhard Weingärtner

Bernhard Weingärtner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9719064
    Abstract: The present invention describes the DNA-sequence of the wild type genome as well as all genetic modifications which were introduced into the wild type—and further developed strains, based thereon. Thereby the first genotypic characterization of the developed strains, including the latest production strain, has been accomplished, accounting for the major part of the invention. Furthermore, on the basis of the determined DNA-sequences, potential genes were identified and account, combined with their functional annotation, for another part of the invention. In particular, the gene- and DNA-sequences, as well as protein-sequences derived there out, contribute to the invention which were affected by mutagenic modifications throughout the strain development process, potentially contributing to the increased production yield.
    Type: Grant
    Filed: August 1, 2011
    Date of Patent: August 1, 2017
    Assignee: BAYER INTELLECTUAL PROPERTY GMBH
    Inventors: Klaus Selber, Bernhard Weingaertner, Hermann Wehlmann, Winfried Rosen, Alfred Pühler, Patrick Schwientek, Jörn Kalinowski, Udo Wehmeier
  • Patent number: 9360111
    Abstract: A piston-cylinder unit includes a cylinder having a closure body at the end. The closure body has a sleeve body which is fixedly connected on one side to the closure body and which is fastened to the cylinder. The sleeve body has a base which supports an operating pressure in the cylinder in direction of the closure body.
    Type: Grant
    Filed: April 18, 2013
    Date of Patent: June 7, 2016
    Assignee: ZF Friedrichshafen AG
    Inventors: Manfred Schuler, Günther Handke, Bernd Zeissner, Bernhard Weingärtner
  • Publication number: 20130302855
    Abstract: The present invention describes the DNA-sequence of the wild type genome as well as all genetic modifications which were introduced into the wild type-and further developed strains, based thereon. Thereby the first genotypic characterization of the developed strains, including the latest production strain, has been accomplished, accounting for the major part of the invention. Furthermore, on the basis of the determined DNA-sequences, potential genes were identified and account, combined with their functional annotation, for another part of the invention. In particular, the gene-and DNA-sequences, as well as protein-sequences derived there out, contribute to the invention which were affected by mutagenic modifications throughout the strain development process, potentially contributing to the increased production yield.
    Type: Application
    Filed: August 1, 2011
    Publication date: November 14, 2013
    Applicant: BAYER INTELLECTUAL PROPERTY GMBH
    Inventors: Klaus Selber, Bernhard Weingaertner, Hermann Wehlmann, Winfried Rosen, Alfred Puhler, Patrick Schwientek, Jörn Kalinowski, Udo Wehmeier
  • Publication number: 20130276625
    Abstract: A The piston-cylinder unit includes a cylinder having a closure body at the end. The closure body has a sleeve body which is fixedly connected on one side to the closure body and which is fastened to the cylinder. The sleeve body has a base which supports an operating pressure in the cylinder in direction of the closure body.
    Type: Application
    Filed: April 18, 2013
    Publication date: October 24, 2013
    Inventors: Manfred SCHULER, Günther HANDKE, Bernd ZEISSNER, Bernhard WEINGÄRTNER
  • Publication number: 20110086013
    Abstract: The present invention is directed to a polynucleotide sequence of a novel acylglycerol acyltransferase-like protein MGAT-X1. The invention also provides the human MGAT-X1 associated with the dermatological diseases, urological diseases, muscle-skeleton disorders, hematological diseases, cancer, reproduction disorders, neurological diseases, metabolic diseases, cardiovascular diseases or gastroenterological diseases. The invention also provides assays for the identification of compounds useful for the modulation of dermatological diseases, urological diseases, muscle-skeleton disorders, hematological diseases, cancer, reproduction disorders, neurological diseases, metabolic diseases, cardiovascular diseases or gastroenterological diseases for treating of such diseases associated with expression of the MGAT-X1. The invention also features compounds which bind to and/or activate or inhibit the activity of MGAT-X1 as well as pharmaceutical compositions comprising such compounds.
    Type: Application
    Filed: August 31, 2010
    Publication date: April 14, 2011
    Applicant: BAYER SCHERING PHARMA AG
    Inventors: Stefan Golz, Ulf Brüggemeier, Bernhard Weingärtner, Andreas Geerts
  • Patent number: 7803593
    Abstract: The present invention is directed to a polynucleotide sequence of a novel acylglycerol acyltransferase-like protein MGAT-X1. The invention also provides the human MGAT-X1 associated with the dermatological diseases, urological diseases, muscle-skeleton disorders, hematological diseases, cancer, reproduction disorders, neurological diseases, metabolic diseases, cardiovascular diseases or gastroenterological diseases. The invention also provides assays for the identification of compounds useful for the modulation of dermatological diseases, urological diseases, muscle-skeleton disorders, hematological diseases, cancer, reproduction disorders, neurological diseases, metabolic diseases, cardiovascular diseases or gastroenterological diseases for treating of such diseases associated with expression of the MGAT-X1. The invention also features compounds which bind to and/or activate or inhibit the activity of MGAT-X1 as well as pharmaceutical compositions comprising such compounds.
    Type: Grant
    Filed: September 16, 2004
    Date of Patent: September 28, 2010
    Assignee: Bayer Schering Pharma AG
    Inventors: Stefan Golz, Ulf Brüggemeier, Bernhard Weingärtner, Andreas Geerts
  • Patent number: 6229000
    Abstract: Disclosed are overlapping cDNA sequences encoding for a human voltage-dependent neuronal calcium channel. The complete cDNA which encodes a voltage-operated calcium channel (VOCC) sub-type is assembled from overlapping lambda phages by means of suitable restriction cleavage sites and cloned into a eukaryotic expression vector.
    Type: Grant
    Filed: May 31, 1995
    Date of Patent: May 8, 2001
    Assignee: Bayer Aktiengesellschaft
    Inventors: Jürgen Franz, Bernhard Weingärtner, Axel Unterbeck, Peter Rae